Patents by Inventor Mark W. Renner

Mark W. Renner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Carbonylporphyrins and uses thereof
    Patent number: 8673265
    Abstract: The present invention is directed to low toxicity boronated compounds and methods for their use in the treatment, visualization, and diagnosis of tumors. More specifically, the present invention is directed to low toxicity carborane-containing porphyrin compounds with halide, amine, or nitro groups and methods for their use particularly in boron neutron capture therapy (BNCT), X-ray radiation therapy (XRT), and photodynamic therapy (PDT) for the treatment of tumors of the brain, head and neck, and surrounding tissue. The invention is also directed to using these carborane-containing porphyrin compounds in methods of tumor imaging and/or diagnosis such as MRI, SPECT, or PET.
    Type: Grant
    Filed: September 10, 2012
    Date of Patent: March 18, 2014
    Assignee: Brookhaven Science Associates, LLC
    Inventors: Michiko Miura, Mark W. Renner
  • Carbonylporphyrins and Uses Thereof
    Publication number: 20130004419
    Abstract: The present invention is directed to low toxicity boronated compounds and methods for their use in the treatment, visualization, and diagnosis of tumors. More specifically, the present invention is directed to low toxicity carborane-containing porphyrin compounds with halide, amine, or nitro groups and methods for their use particularly in boron neutron capture therapy (BNCT), X-ray radiation therapy (XRT), and photodynamic therapy (PDT) for the treatment of tumors of the brain, head and neck, and surrounding tissue. The invention is also directed to using these carborane-containing porphyrin compounds in methods of tumor imaging and/or diagnosis such as MRI, SPECT, or PET.
    Type: Application
    Filed: September 10, 2012
    Publication date: January 3, 2013
    Applicant: Brookhaven Science Associates, LLC
    Inventors: Michiko Miura, Mark W. Renner
  • Carboranylporphyrins and uses thereof
    Patent number: 8287839
    Abstract: The present invention is directed to low toxicity boronated compounds and methods for their use in the treatment, visualization, and diagnosis of tumors. More specifically, the present invention is directed to low toxicity carborane-containing porphyrin compounds with halide, amine, or nitro groups and methods for their use particularly in boron neutron capture therapy (BNCT), X-ray radiation therapy (XRT), and photodynamic therapy (PDT) for the treatment of tumors of the brain, head and neck, and surrounding tissue. The invention is also directed to using these carborane-containing porphyrin compounds in methods of tumor imaging and/or diagnosis such as MRI, SPECT, or PET.
    Type: Grant
    Filed: December 4, 2006
    Date of Patent: October 16, 2012
    Assignee: Brookhaven Science Associates, LLC
    Inventors: Michiko Miura, Mark W. Renner
  • Carboranylporphyrins and uses thereof
    Publication number: 20080131376
    Abstract: The present invention is directed to low toxicity boronated compounds and methods for their use in the treatment, visualization, and diagnosis of tumors. More specifically, the present invention is directed to low toxicity carborane-containing porphyrin compounds with halide, amine, or nitro groups and methods for their use particularly in boron neutron capture therapy (BNCT), X-ray radiation therapy (XRT), and photodynamic therapy (PDT) for the treatment of tumors of the brain, head and neck, and surrounding tissue. The invention is also directed to using these carborane-containing porphyrin compounds in methods of tumor imaging and/or diagnosis such as MRI, SPECT, or PET.
    Type: Application
    Filed: December 4, 2006
    Publication date: June 5, 2008
    Applicant: Brookhaven Science Associates, LLC
    Inventors: Michiko Miura, Mark W. Renner